tiprankstipranks
Sinopharm Group Co Ltd Class H (SHTDF)
OTHER OTC:SHTDF
US Market
SHTDF
Sinopharm Group Co
RESEARCH TOOLSreports

Sinopharm Group Co (SHTDF) Stock Forecast & Price Target

59 Followers
See the Price Targets and Ratings of:

SHTDF Analyst Ratings

Strong Buy
7Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Sinopharm
Group Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHTDF Stock 12 Month Forecast

Average Price Target

$2.98
▲(13.61% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Sinopharm Group Co in the last 3 months. The average price target is $2.98 with a high forecast of $3.41 and a low forecast of $2.53. The average price target represents a 13.61% change from the last price of $2.62.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","4":"$4","1.75":"$1.75","2.5":"$2.5","3.25":"$3.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.4076942999999997,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.9766729342857143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.53088307,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.53</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,1.75,2.5,3.25,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.675,2.7313611,2.7877221999999997,2.8440833,2.9004443999999996,2.9568054999999998,3.0131666,3.0695276999999996,3.1258888,3.1822498999999995,3.2386109999999997,3.2949721,3.3513331999999996,{"y":3.4076942999999997,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.675,2.69820561032967,2.7214112206593404,2.7446168309890107,2.7678224413186814,2.7910280516483517,2.814233661978022,2.837439272307692,2.8606448826373625,2.8838504929670328,2.9070561032967035,2.9302617136263738,2.953467323956044,{"y":2.9766729342857143,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.675,2.6639140823076923,2.6528281646153844,2.641742246923077,2.630656329230769,2.6195704115384615,2.6084844938461536,2.597398576153846,2.586312658461538,2.5752267407692306,2.5641408230769227,2.553054905384615,2.5419689876923073,{"y":2.53088307,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.347,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.248,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.088,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.16,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.41,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.419,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.465,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.575,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.6,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.35,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2.65,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.675,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$3.41Average Price Target$2.98Lowest Price Target$2.53
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
First Shanghai Securities Analyst forecast on SHTDF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$3.41
Buy
30.06%
Upside
Reiterated
04/04/26
Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities
CICC Analyst forecast on SHTDF
Unknown Analyst
CICC
Not Ranked
CICC
$3.15
Buy
20.32%
Upside
Reiterated
03/27/26
Sinopharm Group Co (SHTDF) Receives a Buy from CICC
Huatai Securities Analyst forecast on SHTDF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$2.88
Buy
9.75%
Upside
Reiterated
03/24/26
Huatai Securities Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Daiwa Analyst forecast on SHTDF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$2.68
Buy
2.30%
Upside
Reiterated
03/24/26
Daiwa Reaffirms Their Buy Rating on Sinopharm Group Co (SHTDF)
UBS Analyst forecast on SHTDF
Unknown Analyst
UBS
Not Ranked
UBS
$3.28
Buy
25.19%
Upside
Reiterated
03/23/26
UBS Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Citi Analyst forecast on SHTDF
Unknown Analyst
Citi
Not Ranked
Citi
$2.91
Buy
11.07%
Upside
Reiterated
03/23/26
Citi Sticks to Their Buy Rating for Sinopharm Group Co (SHTDF)
Goldman Sachs Analyst forecast on SHTDF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$2.53
Hold
-3.40%
Downside
Reiterated
03/23/26
Sinopharm Group Co (SHTDF) Gets a Hold from Goldman Sachs
HSBC Analyst forecast on SHTDF
Unknown Analyst
HSBC
Not Ranked
HSBC
$2.3→$2.49
Sell
-5.01%
Downside
Reiterated
11/10/25
HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)
UOB Kay Hian Analyst forecast on SHTDF
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$2.21
Sell
-15.73%
Downside
Reiterated
08/26/25
China Renaissance Analyst forecast on SHTDF
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
$3.01
Buy
14.96%
Upside
Reiterated
08/26/25
Bank of America Securities Analyst forecast on SHTDF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$2.94
Buy
12.04%
Upside
Reiterated
08/25/25
Morgan Stanley Analyst forecast on SHTDF
Laurence Tam
Morgan Stanley
Morgan Stanley
$2.87
Buy
9.61%
Upside
Reiterated
08/22/25
Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group
Citic Securities Analyst forecast on SHTDF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$2.81
Buy
7.17%
Upside
Reiterated
06/16/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
First Shanghai Securities Analyst forecast on SHTDF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$3.41
Buy
30.06%
Upside
Reiterated
04/04/26
Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities
CICC Analyst forecast on SHTDF
Unknown Analyst
CICC
Not Ranked
CICC
$3.15
Buy
20.32%
Upside
Reiterated
03/27/26
Sinopharm Group Co (SHTDF) Receives a Buy from CICC
Huatai Securities Analyst forecast on SHTDF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$2.88
Buy
9.75%
Upside
Reiterated
03/24/26
Huatai Securities Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Daiwa Analyst forecast on SHTDF
Unknown Analyst
Daiwa
Not Ranked
Daiwa
$2.68
Buy
2.30%
Upside
Reiterated
03/24/26
Daiwa Reaffirms Their Buy Rating on Sinopharm Group Co (SHTDF)
UBS Analyst forecast on SHTDF
Unknown Analyst
UBS
Not Ranked
UBS
$3.28
Buy
25.19%
Upside
Reiterated
03/23/26
UBS Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Citi Analyst forecast on SHTDF
Unknown Analyst
Citi
Not Ranked
Citi
$2.91
Buy
11.07%
Upside
Reiterated
03/23/26
Citi Sticks to Their Buy Rating for Sinopharm Group Co (SHTDF)
Goldman Sachs Analyst forecast on SHTDF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$2.53
Hold
-3.40%
Downside
Reiterated
03/23/26
Sinopharm Group Co (SHTDF) Gets a Hold from Goldman Sachs
HSBC Analyst forecast on SHTDF
Unknown Analyst
HSBC
Not Ranked
HSBC
$2.3→$2.49
Sell
-5.01%
Downside
Reiterated
11/10/25
HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)
UOB Kay Hian Analyst forecast on SHTDF
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$2.21
Sell
-15.73%
Downside
Reiterated
08/26/25
China Renaissance Analyst forecast on SHTDF
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
$3.01
Buy
14.96%
Upside
Reiterated
08/26/25
Bank of America Securities Analyst forecast on SHTDF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$2.94
Buy
12.04%
Upside
Reiterated
08/25/25
Morgan Stanley Analyst forecast on SHTDF
Laurence Tam
Morgan Stanley
Morgan Stanley
$2.87
Buy
9.61%
Upside
Reiterated
08/22/25
Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group
Citic Securities Analyst forecast on SHTDF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$2.81
Buy
7.17%
Upside
Reiterated
06/16/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

3 Months
xxx
Success Rate
4/4 ratings generated profit
100%
Average Return
+10.95%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.95% per trade.
1 Year
Laurence TamMorgan Stanley
Success Rate
3/4 ratings generated profit
75%
Average Return
+5.15%
Copying Laurence Tam's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +5.15% per trade.
2 Years
xxx
Success Rate
4/4 ratings generated profit
100%
Average Return
+12.70%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHTDF Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
2
0
0
5
6
Hold
0
0
0
1
1
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
3
1
0
6
7
In the current month, SHTDF has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SHTDF average Analyst price target in the past 3 months is 2.98.
Each month's total comprises the sum of three months' worth of ratings.

SHTDF Financial Forecast

SHTDF Earnings Forecast

The previous quarter’s earnings for SHTDF were $0.09.
The previous quarter’s earnings for SHTDF were $0.09.

SHTDF Sales Forecast

The previous quarter’s earnings for SHTDF were $40.41B.
The previous quarter’s earnings for SHTDF were $40.41B.

SHTDF Stock Forecast FAQ

What is SHTDF’s average 12-month price target, according to analysts?
Based on analyst ratings, Sinopharm Group Co Ltd Class H’s 12-month average price target is 2.98.
    What is SHTDF’s upside potential, based on the analysts’ average price target?
    Sinopharm Group Co Ltd Class H has 13.61% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SHTDF a Buy, Sell or Hold?
          Sinopharm Group Co Ltd Class H has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Sinopharm Group Co Ltd Class H’s price target?
            The average price target for Sinopharm Group Co Ltd Class H is 2.98. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $3.41 ,the lowest forecast is $2.53. The average price target represents 13.61% Increase from the current price of $2.62.
              What do analysts say about Sinopharm Group Co Ltd Class H?
              Sinopharm Group Co Ltd Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of SHTDF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.